Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer. (April 2021) - Ruiz-Borrego, M.; Chan, A.; Marx, G.; Brufsky, A.; Trudeau, M.; Egle, D.; McCulloch, L.; Tripathy, D.; Barcenas, C.H.